共 50 条
- [31] Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathyBlood Cancer Journal, 13Maria MoscvinChristine Ivy LiacosTianzeng ChenFoteini TheodorakakouDespina FotiouShahrier HossainSean RowellHoury LeblebjianEileen ReganPeter CzarneckiFilippo BagnoliNiccolo’ BolliPaul RichardsonHelmut G. RennkeMeletios A. DimopoulosEfstathios KastritisGiada Bianchi
- [32] Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathyBLOOD CANCER JOURNAL, 2023, 13 (01)Moscvin, MariaLiacos, Christine IvyChen, TianzengTheodorakakou, FoteiniFotiou, DespinaHossain, ShahrierRowell, SeanLeblebjian, HouryRegan, EileenCzarnecki, PeterBagnoli, FilippoBolli, Niccolo'Richardson, PaulRennke, Helmut G.Dimopoulos, Meletios A.Kastritis, EfstathiosBianchi, Giada
- [33] Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathwayBIOMEDICINE & PHARMACOTHERAPY, 2023, 164Dabour, Mohamed S.Abdelgawad, Ibrahim Y.Grant, Marianne K. O.El-Sawaf, Engie S.Zordoky, Beshay N.
- [34] Mutations in the Alternative Complement Pathway in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic MicroangiopathyBLOOD, 2021, 138Moscvin, MariaLiacos, Christine IvyChen, TianzengTheodorakakou, FoteiniFotiou, DespinaRegan, EileenKastritis, EfstathiosDimopoulos, Meletios A.Richardson, Paul G.Bianchi, Giada
- [35] Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturationLEUKEMIA, 2020, 34 (02) : 651 - 655Kint, Nicolas G.Heylen, ElienPepe, DanieleDe Keersmaecker, KimVerfaillie, Catherine M.Delforge, Michel
- [36] Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature ReviewKIDNEY AND DIALYSIS, 2022, 2 (04): : 625 - 637Pallotti, FedericaQueffeulou, ClaireBellal, MathieuJean-Jacques, BastienGac, Anne-ClaireChatelet, ValerieBoyer, AnnabelGueutin, Victor
- [37] Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular eventsBLOOD ADVANCES, 2019, 3 (11) : 1725 - 1728Abe, YoshiakiKobayashi, TetsuyaNarita, KentaroKobayashi, HirokiKitadate, AkihiroMiura, DaisukeTakeuchi, MasamiMatsue, Kosei
- [38] Carfilzomib-induced acute cardiotoxicity is mediated through angiotensin and caused by cardiomyocyte energy depletionCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S122 - S122Mendez, MaxAndrej, BesseFlorea, BogdanChristian, ZuppingerOverkleeft, HermenLenka, BesseDriessen, Christoph
- [39] Investigating the impact of aging and hyperlipidaemia on metformin cardioprotection against carfilzomib-induced cardiotoxicity in vivoEUROPEAN HEART JOURNAL, 2020, 41 : 3400 - 3400Psarrakou, G.Chatzistefanou, M.Efenlakis, P.Varela, A.Papanagnou, E. D.Nikolaou, P. E.Tsouinani, M.Davos, C. H.Kastritis, E.Trougakos, I. P.Dimopoulos, M. A.Terpos, E.Andreadou, I
- [40] Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective studyLEUKEMIA, 2021, 35 (05) : 1418 - 1427Kastritis, EfstathiosLaina, AgelikiGeorgiopoulos, GeorgiosGavriatopoulou, MariaPapanagnou, Eleni-DimitraEleutherakis-Papaiakovou, EvangelosFotiou, DespinaKanellias, NikolaosDialoupi, IoannaMakris, NikolaosManios, EfstathiosMigkou, MagdaliniRoussou, MariaKotsopoulou, MariaStellos, KonstantinosTerpos, EvangelosTrougakos, Ioannis P.Stamatelopoulos, KimonDimopoulos, Meletios A.